urea has been researched along with Coronary Artery Disease in 11 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Postoperative intravenous landiolol therapy followed by oral carvedilol may be more effective than oral carvedilol alone for prevention of atrial fibrillation after off-pump CABG." | 9.16 | Effect of postoperative landiolol administration for atrial fibrillation after off pump coronary artery bypass surgery. ( Bessho, R; Fujii, M; Ochi, M; Shimizu, K; Takeda, S; Terajima, K, 2012) |
| "Administration of landiolol using the presently recommended dosage and administration route causes a decrease in HR without aggravation of hemodynamics in patients with normal cardiac function, but in patients with preoperative EF lower than 50%, it may lead to further deterioration of cardiac function due to a decrease in HR." | 6.73 | The effect of landiolol on hemodynamics and left ventricular function in patients with coronary artery disease. ( Goto, K; Miyakawa, H; Miyamoto, S; Noguchi, T; Shingu, C, 2007) |
| "Postoperative intravenous landiolol therapy followed by oral carvedilol may be more effective than oral carvedilol alone for prevention of atrial fibrillation after off-pump CABG." | 5.16 | Effect of postoperative landiolol administration for atrial fibrillation after off pump coronary artery bypass surgery. ( Bessho, R; Fujii, M; Ochi, M; Shimizu, K; Takeda, S; Terajima, K, 2012) |
| " Here we investigate the hypothesis that increased concentrations of urea associated with CRF increase ROS production directly in EPCs, causing abnormalities associated with coronary artery disease risk." | 3.85 | Urea-induced ROS accelerate senescence in endothelial progenitor cells. ( Brownlee, M; Capozzi, V; Colia, AL; D'Apolito, M; Falcone, MP; Giardino, I; Lasalvia, M; Maffione, AB; Pettoello-Mantovani, M, 2017) |
| "Landiolol hydrochloride was continuously administered intravenously to 145 patients before starting MSCT CAG." | 2.73 | Feasibility of intravenous administration of landiolol hydrochloride for multislice computed tomography coronary angiography: initial experience. ( Ishii, H; Isobe, S; Kato, M; Kobayashi, M; Meno, C; Mimura, T; Murohara, T; Sato, K; Sugiura, K, 2008) |
| "Administration of landiolol using the presently recommended dosage and administration route causes a decrease in HR without aggravation of hemodynamics in patients with normal cardiac function, but in patients with preoperative EF lower than 50%, it may lead to further deterioration of cardiac function due to a decrease in HR." | 2.73 | The effect of landiolol on hemodynamics and left ventricular function in patients with coronary artery disease. ( Goto, K; Miyakawa, H; Miyamoto, S; Noguchi, T; Shingu, C, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Kiyokuni, M | 1 |
| Konishi, M | 1 |
| Saigusa, Y | 1 |
| Iwata, K | 1 |
| Nakayama, N | 1 |
| Komura, N | 1 |
| Sugano, T | 1 |
| Ishigami, T | 1 |
| Ishikawa, T | 1 |
| Yamanaka, T | 1 |
| Tamura, K | 1 |
| Kimura, K | 1 |
| D'Apolito, M | 1 |
| Colia, AL | 1 |
| Lasalvia, M | 1 |
| Capozzi, V | 1 |
| Falcone, MP | 1 |
| Pettoello-Mantovani, M | 1 |
| Brownlee, M | 1 |
| Maffione, AB | 1 |
| Giardino, I | 1 |
| Widder, JD | 1 |
| Cortese, B | 1 |
| Levesque, S | 1 |
| Berliner, D | 1 |
| Eccleshall, S | 1 |
| Graf, K | 1 |
| Doutrelant, L | 1 |
| Ahmed, J | 1 |
| Bressollette, E | 1 |
| Zavalloni, D | 1 |
| Piraino, D | 1 |
| Roguin, A | 1 |
| Scheller, B | 1 |
| Stella, PR | 1 |
| Bauersachs, J | 1 |
| Bencsik, P | 1 |
| Sasi, V | 1 |
| Kiss, K | 1 |
| Kupai, K | 1 |
| Kolossváry, M | 1 |
| Maurovich-Horvat, P | 1 |
| Csont, T | 1 |
| Ungi, I | 1 |
| Merkely, B | 1 |
| Ferdinandy, P | 1 |
| Isobe, S | 2 |
| Sato, K | 2 |
| Sugiura, K | 2 |
| Mimura, T | 2 |
| Kobayashi, M | 2 |
| Meno, C | 2 |
| Kato, M | 2 |
| Ishii, H | 2 |
| Murohara, T | 2 |
| Wakamatsu, H | 1 |
| Watanabe, T | 1 |
| Sato, Y | 1 |
| Takase, S | 1 |
| Omata, S | 1 |
| Yokoyama, H | 1 |
| Fujii, M | 1 |
| Bessho, R | 1 |
| Ochi, M | 1 |
| Shimizu, K | 1 |
| Terajima, K | 1 |
| Takeda, S | 1 |
| MCKECHNIE, JK | 1 |
| DAVIDSON, FJ | 1 |
| Türker, H | 1 |
| Dönmez, A | 1 |
| Zeyneloğlu, P | 1 |
| Sezgin, A | 1 |
| Uluçam, M | 1 |
| Goto, K | 1 |
| Shingu, C | 1 |
| Miyamoto, S | 1 |
| Miyakawa, H | 1 |
| Noguchi, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Drug-Coated Balloon for the Treatment of De Novo and Restenotic Coronary Artery Lesion: a Prospective Observational Study[NCT05562089] | 50 participants (Anticipated) | Interventional | 2022-04-29 | Enrolling by invitation | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 trials available for urea and Coronary Artery Disease
| Article | Year |
|---|---|
Randomized controlled trial of landiolol, a short-acting beta-1 adrenergic receptor blocker, illustrating changes in high-molecular weight adiponectin levels after elective percutaneous coronary intervention.
Topics: Adiponectin; Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Angina, Stable; Biomar | 2020 |
Use of landiolol hydrochloride, a new beta-blocker, in coronary computed tomography angiography.
Topics: Adrenergic beta-Antagonists; Aged; Coronary Angiography; Coronary Artery Disease; Female; Humans; Ma | 2010 |
Feasibility of intravenous administration of landiolol hydrochloride for multislice computed tomography coronary angiography: initial experience.
Topics: Aged; Anti-Arrhythmia Agents; Blood Pressure; Coronary Angiography; Coronary Artery Disease; Coronar | 2008 |
Effect of postoperative landiolol administration for atrial fibrillation after off pump coronary artery bypass surgery.
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Coronary Artery Bypass, Off-Pump; Coronary A | 2012 |
Effects of enalaprilat infusion on hemodynamics and renal function in patients undergoing cardiac surgery.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiac Output; Cardiopulmonary Bypass; Coronary Artery Di | 2004 |
The effect of landiolol on hemodynamics and left ventricular function in patients with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Blood Pressure; Cardiac Output; Catheterization, | 2007 |
5 other studies available for urea and Coronary Artery Disease
| Article | Year |
|---|---|
Urea-induced ROS accelerate senescence in endothelial progenitor cells.
Topics: Adenoviridae; Cell Differentiation; Cellular Senescence; Coronary Artery Disease; Endothelial Progen | 2017 |
Coronary artery treatment with a urea-based paclitaxel-coated balloon: the European-wide FALCON all-comers DCB Registry (FALCON Registry).
Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Dru | 2019 |
Serum lipids and cardiac function correlate with nitrotyrosine and MMP activity in coronary artery disease patients.
Topics: Aged; Biomarkers; Coronary Artery Disease; Female; Heart; Humans; Hydroxymethylglutaryl-CoA Reductas | 2015 |
Landiolol reduces coronary artery motion in an open-chest porcine model: implications for off-pump coronary artery bypass surgery.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Artery Bypass, Off-Pump; Coronary Artery Disease; Cor | 2012 |
CORONARY ARTERY DISEASE IN NATAL INDIANS.
Topics: Aspartate Aminotransferases; Blood Chemical Analysis; Blood Pressure Determination; Cholesterol; Cor | 1964 |